In this study, we demonstrate, for the first time, that the intracellular form of CYTL1, not the extracellular form, inhibits metabolic reprogramming toward glycolysis, which has been linked to the inhibition of the cell growth and metastasis of breast cancer both in vitro and in vivo. This evidence concerns the gene CYTL1 and breast cancer.